Bb-yaiba no.10.12

Safety and Efficacy of Subcutaneous Ianalumab (VAY736) in Patients with Primary Sjögren's Syndrome: A Randomised, Double-blind, Placebo-controlled, Phase 2b Dose-finding Trial

Bowman, Simon J, Fox, Robert, Dörner, Thomas, Mariette, Xavier, Papas, Athena, Grader-Beck, Fisher, Benjamin A, Barcelos, Filipe, De Vita, Salvatore, Schulze-Koops, Hendrik, Moots, Robert J, Junge, Guido, Woznicki, Janice N, Sopala, Monika A, Luo, Wen-Lin, Hueber, Wolfgang